Keros Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 3.43, 1.64, 39.19, 69.77, 107.7 ], "ebit_estimate": [ -132.83, -143.02, -122.38, -139.55, -84.65 ], "ebitda_estimate": [ -125.78, -89.01, -210.4, null, null ], "net_income_estimate": [ -117.33, -134.39, -124.06, -136.36, -82.88 ], "per_share_eps_estimate": [ -5.82, -5.41, -4.51, -4.25, -1.98 ], "eps_nri_estimate": [ -5.82, -5.41, -4.51, -4.25, -1.98 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -117.33, -134.39, -127.85, -139.22, -83.65 ], "operating_cash_flow_per_share_estimate": [ -3.41, -1.15, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -36.89, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 94.2 ], "operating_cash_flow_estimate": [ -66.94, -22.58, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 0.81, 1.59, 0.78, 0.43, 0.43, 0.43, 0.43, null ], "ebit_estimate": [ -29.89, -33.19, -40.47, -37.4, -36.9, -40.9, -45.9, null ], "ebitda_estimate": [ -29.33, -27.41, -40.01, null, null, null, null, null ], "net_income_estimate": [ -26.77, -29.96, -36.81, -36.25, -36.25, -40.25, -45.75, null ], "per_share_eps_estimate": [ -1.34, -1.47, -1.79, -1.48, -1.53, -1.62, -1.79, null ], "eps_nri_estimate": [ -1.34, -1.47, -1.79, -1.48, -1.53, -1.62, -1.79, -2.18 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -27.26, -31.29, -37.98, -36.25, -36.25, -40.25, -45.75, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 100, 100, 100, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }